Huilin Zhu
About Huilin Zhu
Huilin Zhu is the Director of Clinical Operations at BeiGene in Shanghai, with over 14 years of experience in clinical pharmacology and clinical trial management.
Current Title and Role
Huilin Zhu currently serves as the Director of Clinical Operations at BeiGene in Shanghai, China. She joined the company in September 2020. In this role, she is responsible for overseeing clinical operations, ensuring that clinical trials are conducted effectively and efficiently.
Previous Experience at Eli Lilly
Before joining BeiGene, Huilin Zhu worked for Eli Lilly China as the Associate Director of Clinical Trial Management from 2018 to 2020. She also held a senior role as the Clinical Pharmacology & Lab Ops Manager from 2006 to 2018. During her 14-year tenure at Eli Lilly, she gained a wealth of experience in clinical pharmacology, lab operations, and clinical trial management in Shanghai.
Education and Qualifications
Huilin Zhu holds a Master of Public Health (MPH) degree from Fudan University, obtained between 2011 and 2014. She also earned a Bachelor's degree in Pharmacology from the same university, completing her studies from 2002 to 2006. Her strong academic background in both pharmacology and public health has equipped her with the necessary skills to excel in the field of clinical operations.
Industry Experience
Huilin Zhu has over 14 years of experience in clinical pharmacology and clinical trial management. Her extensive background includes managing clinical trials, overseeing clinical pharmacology projects, and leading lab operations. Her work has primarily been based in Shanghai, China, where she has contributed significantly to the field of clinical operations.
Professional Background at BeiGene
Since September 2020, Huilin Zhu has been with BeiGene, a notable biotechnology company. As the Director of Clinical Operations, she plays a critical role in steering clinical operations to ensure compliance and efficiency in clinical trials. Her responsibilities include planning, executing, and managing clinical trials to support the company's research and development objectives.